Overview

Effects of Lysozyme on Acute Exacerbation of Chronic Obstructive Pulmonary Disease : A Randomised Placebo-Controlled Study

Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to assess the effectiveness in preventing exacerbation of 52 weeks lysozyme administration in patients with COPD.
Phase:
Phase 4
Details
Lead Sponsor:
Eisai Co., Ltd.
Treatments:
Muramidase